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a b s t r a c t
Avian inﬂuenza A (H9N2) viruses have occasionally been identiﬁed in humans with upper respiratory
tract infections. The novel H7N9/2013 virus identiﬁed in China shows that a low pathogenic avian
inﬂuenza (LPAI) virus can be highly pathogenic in humans. Therefore, it is important to understand
virus–host cell interactions and immune responses triggered by LPAI viruses in humans. We found that
LPAI A/Hong Kong/1073/99 (H9N2) virus replicated efﬁciently in human dendritic cells (DCs). The H9N2
virus induced strong IFN gene expression although with different kinetics than seasonal inﬂuenza A/
Beijing/353/89 (H3N2) virus. IFN inducible antiviral proteins were produced in H9N2 virus-infected cells
at the same level as in H3N2 infection. The H9N2 virus was extremely sensitive to the antiviral actions of
type I IFNs. These results indicate that the avian inﬂuenza H9N2 virus is inducing a strong antiviral IFN
response in human DCs.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Birds, especially waterfowl, are natural reservoirs of inﬂuenza
viruses. From birds inﬂuenza viruses, such as the H5, H7, H9 and
H10 subtypes, can be directly transmitted to mammals, including
humans (Chan, 2002). Avian inﬂuenza became of great concern in
1997 when the ﬁrst outbreak of highly pathogenic avian inﬂuenza
(HPAI) A H5N1 virus in humans occurred in Hong Kong (Chan,
2002). According to the World Health Organization (WHO), infec-
tions by the HPAI H5N1 virus have lead to a lethal outcome in
nearly 60% of documented human cases (WHO, 2014). In 2003
HPAI H7N7 virus caused a small epidemic in humans with one
death (Fouchier et al., 2004). Since then H7N7 subtype viruses
have caused more than 100 cases of human infections (WHO,
2014). A totally new threat for humans emerged in March 2013
when human infections with an avian inﬂuenza A H7N9 virus
were reported. This was the ﬁrst time when an H7N9 virus was
found in humans and it was overall the ﬁrst time when a low
pathogenic avian inﬂuenza virus caused severe illness in humans
(WHO, 2014; Gao et al., 2013). After that, due to enhanced
inﬂuenza surveillance activity, other new avian inﬂuenza viruses
were found to cause infections in humans, such as H6N1 and
H10N8 (WHO, 2014). These cases demonstrate how serious threats
low pathogenic avian inﬂuenza viruses may represent for humans.
Inﬂuenza A virus subtype H9N2 is a low pathogenic avian
inﬂuenza virus (LPAI). H9N2 viruses are widespread in birds in Asia
and in the Middle-East (Alexander, 2007), and occasionally H9N2
virus has been transmitted from poultry to mammalian species,
including humans and pigs (WHO, 2014; Peiris et al., 1999). Since
1999, when the ﬁrst human infection was detected (Peiris et al.,
1999), the isolation of H9N2 viruses from humans and swine has
been reported infrequently. The most recent human case of H9N2
infection was detected in China at the end of the year 2013 (WHO,
2014). All human patients with H9N2 infection have experienced a
mild inﬂuenza-like illness and have fully recovered. So far there has
been no evidence of human-to-human transmission of H9N2 viruses.
However, some of the H9N2 viruses currently circulating in birds
have receptor speciﬁcity similar to that of human H3N2 viruses, i.e.
they have the ability to bind to oligosaccharides terminating with a
sialic acid linked to galactose via a α2,6-linkage (SAα2–6, human-
type receptor) (Matrosovich et al., 2001; Guan et al., 2000). Adapta-
tion to human-type receptors enables the virus to infect and replicate
in mammalian hosts which increases the risk of a pandemic.
A/Hong Kong/1073/1999 (H9N2) virus was isolated from a
4-year-old girl in Hong Kong in 1999. The girl had a history of mild
eczema and asthma from 3 years of age. She was admitted to the
hospital with fever and other inﬂuenza-like symptoms. Her fever
settled within 6 days and she recovered (Peiris et al., 1999).
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The H9N2/99 virus contains internal genes similar to those of the
highly pathogenic avian inﬂuenza A/Hong Kong/156/1997 (H5N1)
-like viruses which have caused fatal infections in humans.
Although avian inﬂuenza viruses of the H9 subtype preferentially
bind to α-2,3 linked (avian-type) sialic acid, the A/Hong Kong/1073/
1999 virus has the ability to bind to both α-2,3 and α-2,6 linked
sialic acids which may indicate a broader host range, including
humans (Guan et al., 2000; Lin et al., 2000).
Dendritic cells (DCs) are important immune cells, which
orchestrate the formation of effective innate immune responses
against microbes by producing regulatory cytokines. They are the
principal antigen-presenting cells inducing proliferation and acti-
vation of T cells, and thus are bridging the innate and adaptive
immunity. Together with DCs, alveolar macrophages reside close
to the epithelium of the respiratory tract, which all form the front
barrier against inﬂuenza viruses. Together these immune cells by
sensing invading viruses initiate the antiviral responses to inhibit
replication and spread of the virus in inﬂamed tissues (Seo et al.,
2004; Moltedo et al., 2009). The genome of an inﬂuenza virus is
mainly recognized by retinoic acid inducible gene-I (RIG-I), which
primarily detects RNAs carrying 50-triphosphate (Pichlmair et al.,
2006). Toll-like receptors (TLRs) 3 and 7 preferentially recognize
double-stranded RNA (dsRNA) and single-stranded RNA (ssRNA),
respectively (Akira et al., 2006). Recognition of viral genetic
material activates the antiviral signaling cascades in host cells
leading to the transcriptional regulation of a range of cytokine
genes. NF-κB, ATF2-c-Jun, IRF3 and IRF7 are the main transcription
factors that regulate the expression of type I and III interferons
(IFNs) and proinﬂammatory cytokines (Österlund et al., 2007;
Marié et al., 1998), all of which contribute to innate antiviral
responses against inﬂuenza viruses (Österlund et al., 2005; Ronni
et al., 1997). In addition to cytokine responses, virus infection also
induces the expression of many antiviral proteins, which have a
role in the progression of the infection (Haller and Kochs, 2011;
Diamond and Farzan, 2013; Min and Krug, 2006; Min et al., 2007).
Although there have been several human infections caused by
the H9N2 virus, the innate immune responses in human cells have
remained uncharacterized. Thus, in the present study we analyzed
H9N2 virus-induced innate immune responses in human
monocyte-derived dendritic cells (moDCs), focusing on the expres-
sion of proinﬂammatory cytokine and antiviral IFN genes, the
activation of transcription factors regulating these genes and the
expression of antiviral proteins. We observed that the H9N2 virus
replicated efﬁciently in human moDCs, and that H9N2 virus
infection induced both IFNs and proinﬂammatory cytokine
responses. We also found out that the H9N2 virus was extremely
sensitive to the antiviral actions of type I IFNs (IFN-α and IFN-β).
Results
Avian inﬂuenza A (H9N2) virus replicates efﬁciently in human moDCs
To investigate the replication of the avian H9N2 virus in human
immune cells, human moDCs were infected with the A/Hong
Kong/1073/1999 (H9N2/99) virus. Inﬂuenza A/Beijing/353/1989
(H3N2/89) virus was used as control virus for which innate
Fig. 1. Inﬂuenza A (H9N2) virus replicates effectively in human moDCs. Human
monocyte-derived DCs (moDC) are infected with human seasonal inﬂuenza A/
Beijing/353/1989 (H3N2) or avian-origin inﬂuenza A/Hong Kong/1073/1999
(H9N2) viruses at MOI of 1, cells are harvested at different time points after
infection as indicated. (A) Total cellular RNA samples are isolated for qRT-PCR
analysis of the viral M1-speciﬁc RNAs. The expression levels of viral M1 gene are
presented in relation to that of the 30 min sample, representing increases in the
viral RNA levels during the time course of infection. The results are presented as
means from triplicate measurements with standard deviations. The n symbols
indicate statistical signiﬁcance of differences in RNA expression level in a given
time point between H3N2 and H9N2 viruses, npo0.05 (Student's t test). (B) The
whole cell lysates are prepared and viral NP and M1 proteins are analyzed by
Western blotting. Total cellular IRF3 is analyzed from the same blot to control for
equal loading. The data is representative of 4 independent experiments. For RNA
and protein lysates the cells from four different blood donors are pooled after
infection experiment. (C) For analyzing the cell viability during the virus infection,
cells are stained and ﬁxed for ﬂow cytometric analysis. Cells from four different
blood donors are handled separately, and data on percentage of dead cells is
presented as mean values with standard deviations. Histograms show the
ﬂuorescence intensities of the staining color in samples of one donor.
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immune responses in this cell model are well deﬁned (Österlund
et al., 2005, 2012).
The plaque-forming units (PFU) and the hemagglutination (HA)
titers of the H3N2/89 and H9N2/99 virus stocks were determined.
Both titrations gave similar difference in the infectivity between
the virus stocks, i.e. 2107 PFU/ml and 1.6108 PFU/ml, and 128
and 512–1024 for HA titer, respectively. Both viruses were used at
an equal multiplicity of infection (MOI), which is given according
to the PFU titers determined in MDCK cells.
Virus replication was analyzed from viral RNA and protein
expression by qRT-PCR and immunoblotting, respectively. In virus-
infected human moDCs (at MOI of 1) relative viral matrix protein 1
(M1) RNA expression increased effectively during the time of
infection with both H3N2/89 and H9N2/99 viruses (Fig. 1A). Both
virus strains expressed notable amounts of nucleoprotein (NP) and
M1 protein in the infected cells at 8 h and 24 h time points after
infection (Fig. 1B). Virus infection was also observed microscopi-
cally by detecting the cells cytopathic effect (CPE; data not shown).
Although both H3N2/89 and H9N2/99 viruses resulted in explicit
infection in moDCs, still H9N2/99 virus infection led to more
distinct CPE than what was seen in moDCs infected with H3N2/89
virus (data not shown). However, viability analysis of the cells over
the course of virus infection showed no differences in the propor-
tions of dead cells between H3N2/89 and H9N2/99 infected cells
(Fig. 1C). Furthermore, for comparing the maturation status of
moDCs induced by the H9N2/99 virus infection to that induced by
the H3N2/89 virus, which have been shown to inefﬁciently induce
DC maturation (Österlund et al., 2005), the expression of costimu-
latory molecule CD86 and HLA-II was analyzed by FACS. Our
results conﬁrmed that neither the H9N2/99 avian-origin virus
nor the H3N2/89 virus is able to induce efﬁcient maturation of
moDCs (Supplementary Fig. 1). The results showed that like the
human H3N2/89 virus, also the avian-origin H9N2/99 virus was
able to infect human moDCs and to replicate efﬁciently in these
cells inducing strong cell-death already within 24 h of infection.
H9N2 virus infection induces strong IFN response
Given that the IFN system is the most important host defense
mechanism during virus infection by restricting the virus growth
and initiating immune responses, we wanted to compare the
induction of IFN responses in moDCs triggered by the avian-
origin H9N2/99 and the human seasonal H3N2/89 viruses. After
infecting the cells, total cellular RNA samples were collected at
different time points, and qRT-PCR was carried out to quantitate
cytokine mRNA levels. Both H3N2/89 and H9N2/99 viruses
induced antiviral IFN-β, IFN-α and IFN-λ1 gene expression in
moDCs but a clear difference in the kinetics of the IFN gene
expression between these viruses was seen (Fig. 2A). Interestingly,
in H9N2 virus-infected cells IFN mRNA expression took place
somewhat earlier, peaking at 6–8 h after infection as compared
to cells infected by the H3N2/89 virus where the peak IFN mRNA
expression levels were seen at 8–24 h after infection (Fig. 2A).
Furthermore, we determined IFN protein levels in culture super-
natants from cells infected with serially diluted viruses with an
ELISA test and we found that H3N2/89 or H9N2/99 virus-infected
cells produced similar amounts of IFN-α and IFN-β during the
infection experiment (24 h) (Fig. 2B). Thus, the downregulation of
the IFN mRNA expression seen in the late times of H9N2/99
infection did not reﬂect to the accumulation of produced IFNs
during the whole infection period.
Fig. 2. Interferon responses induced by H3N2 and H9N2 virus infection. (A) moDCs
were infected with H3N2 or H9N2 viruses at MOI of 1 for various periods of times.
Cells from four different blood donors are pooled and cellular RNA is isolated.
Virus-induced IFN-α, IFN-β, and IFN-λ1 gene expression is analyzed by quantitative
RT-PCR. The values are normalized to 18S rRNA and presented as relative gene
expression in relation to the RNA sample obtained from uninfected control moDCs.
Values from triplicate measurements are presented as means and standard
deviations. The experiment is repeated 4 times. The n symbols indicate signiﬁcant
differences between H3N2 and H9N2 viruses, npo0.05. (B) To analyze the secreted
IFN-α and IFN-β protein levels with an ELISA assay, cell culture supernatants are
collected from virus-infected moDCs at 24 h post-infection. Cells were infected
with different doses of inﬂuenza (MOI 0.01; 0.05; 0.25; 1.25; 6; 31; 100 from left to
right). The samples are analyzed as duplicate in the assay. The results are from four
different blood donors analyzed separately and presented as mean values with
standard deviations.
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Several transcription factors are involved in the regulation of
cytokine gene expression during inﬂuenza virus infection. To reveal
the transcriptional regulation of IFN responses in H9N2 infection,
we analyzed the expression levels of different regulatory factors in
H9N2/99 and H3N2/89 virus-infected cells. IRF3 is one of the most
important transcription factors regulating the early antiviral genes
after viral recognition-induced signaling. Interestingly, the phos-
phorylation of IRF3 was remarkably stronger in moDCs infected
with H3N2/89 virus than in H9N2/99 virus-infected cells although
the IRF3 phosphorylation started to become visible at the same
time point (6 h) of infection by both viruses (Fig. 3). The faint
activation of IRF3 by the avian-origin H9N2 virus is well in line with
that seen by the novel LPAI H7N9 virus in human moDCs (Arilahti et
al., 2014). The expression of other important IRFs regulating the
antiviral IFN genes was also analyzed, and the expression of IRF1
and IRF7 did not differ notably between H9N2/99 or H3N2/89 virus-
infected cells. Also, there was no detectable difference in the
phosphorylation of p38 MAP kinase between these viruses, but
the phosphorylated form of signal transducers and the activators of
transcription 1 (STAT1) was expressed at two fold higher level in
cells infected with H9N2/99 virus (Fig. 3).
Next we studied the activation of the NFκB transcription factor
by monitoring the degradation of IκBα. IκBα amount is inversely
proportional to the amount of transcriptionally active NFκB since
IκBα is a multifunctional inhibitor of NFκB (Jacobs and Harrison,
1998). Comparing the amount of IκBα in H3N2/89 and H9N2/99
virus-infected cells, there was no difference in the levels of IκBα in
cells infected with H9N2/99 or H3N2/89 virus (Fig. 3). Altogether
the activation of transcription factors regulating the antiviral IFN
genes seems not to be very different in cells infected with H3N2/
89 virus as compared with H9N2/99 virus-infected cells. Based on
these results it seems clear that the H9N2/99 virus can activate the
human immune system, but the activation of any speciﬁc tran-
scription factor may not alone explain the temporal difference in
IFN responses between these viruses.
Proinﬂammatory cytokine and chemokine gene expression in moDCs
infected with H3N2 and H9N2 inﬂuenza A viruses
It has been shown that human infection with H5N1 avian
inﬂuenza virus leads to a massive pro-inﬂammatory cytokine and
chemokine response, which can contribute to the severe outcome
of the disease (de Jong et al., 2006). To analyze whether the avian
inﬂuenza virus H9N2 can also trigger robust cytokine responses, we
investigated the expression of proinﬂammatory cytokine TNF-α and
IL-1β and chemokine CXCL10 and CCL5 genes in H3N2/89 or H9N2/
99 virus-infected moDCs. The relative expression of TNF-α and IL-
1β mRNAs decreased after 6 h of infection with H9N2/99 virus but
maximal expression levels were similar with both types of viruses
(Fig. 4A). The expression level of CXCL10 gene was stronger in
H9N2-infected cells as compared to that of H3N2/89 infection
(Fig. 4A). These ﬁndings suggest that the avian-origin H9N2/99
virus and the seasonal H3N2/89 virus induce overall a very similar
proinﬂammatory immune response in human immune cells.
Since adaptive immunity, together with innate immunity, takes
part in the clearance of inﬂuenza virus infection we also analyzed
the expression of IL-12, which is an important regulator in the
development of the Th1 and Th17 types of adaptive immunity
(Vignali and Kuchroo, 2012). The gene expression of p35 and p40
subunits of IL-12 was very similar in H9N2/99 and in H3N2/89
virus-infected cells (Fig. 4B). It was clearly visible that the expres-
sion of IL-12 subunit p40 peaked already at 3–6 h time points
whereas the expression of p35 subunit clearly increased at 24 h
post-infection with H3N2/89 and H9N2/99 viruses.
IRF3, IRF7 and NFκB transcription factors regulate innate immune
responses induced by avian inﬂuenza H9N2 virus
As shown in Fig. 3, there are not many differences in between
transcription factor activation during H9N2 and H3N2 virus infec-
tions in moDCs. Thus, to further explore the importance of certain
transcription factors in regulating the cytokine genes during human
or avian inﬂuenza infections, we used mouse embryonic ﬁbroblasts
(MEFs) devoid of NFκB or IRF3 and IRF7 to analyze whether these
factors are involved in H9N2 and H3N2 virus-induced cytokine
responses. H3N2/89 and H9N2/99 viruses replicated efﬁciently in
both wild type and knock-out (KO) cells as evidenced by the
expression of viral M1 RNA (Fig. 5). Seasonal inﬂuenza viruses
activate IRF3 and NFκB and induce the expression of IRF7 transcrip-
tion factor, which are signiﬁcant in regulating innate immunity
during the infection (Ehrhardt et al., 2010). Here we showed that in
both NFκB KO and IRF3/7 KO cells H9N2/99 virus-induced IFN-β
Fig. 3. Activation of transcription factors stimulated by H3N2 and H9N2 virus infection. (A) The expression of signaling molecules P-IRF3, IRF3, IRF1, IRF7, P-p38 MAPK and
P-STAT1, and expression of IκBα, inhibitor for the transcriptionally active form of NFκB is analyzed from virus-infected moDCs at different time points as indicated by the
Western blot technique. GAPDH and actin are stained for loading control. Cells from four different donors are pooled for immunoblot analysis. Western blot bands are
quantitated and expression of signaling molecules in relation to the loading control is presented as fold induction over CTRL. A representative experiment out of 3 is shown.
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and CXCL10 gene expression was signiﬁcantly reduced whereas the
expression of these cytokine genes readily took place in wild type
cells (Fig. 5). The expression of IFN-β and CXCL10 was also inhibited
in H3N2/89 infection in both types of KO cells. However, in mouse
cells, the human H3N2/89 virus-induced TNF-α expression was
appeared to be completely independent on IRF3 and IRF7 whereas
the avian-origin H9N2/99 virus was overall unable to induce TNF-α
expression at a notable level. The cytokine gene expression levels as
a whole were lower in H9N2/99 virus-infected mouse cells as
compared to those seen in H3N2/89 virus-infected cells (Fig. 5).
Expression of regulators of innate immunity and antiviral proteins
during H9N2 virus infection
IFNs mediate the activation of different antiviral proteins in a
paracrine and autocrine fashion that contribute to the antiviral state
in the responding cell. The development of antiviral status is regu-
lated by various modulators at different points of the activation
cascade. To analyze the regulation of antiviral status in H9N2 and
H3N2 virus infections, we analyzed the expression of interferon-
induced protein with tetratricopeptide repeats 3 (IFIT3) and sup-
pressor of cytokine signaling 3 (SOCS3). SOCS3 is a negative feed-
back regulator of innate immune responses, especially of type I IFN
signaling (Pothlichet et al., 2008), which may contribute to down-
regulation of robust inﬂammatory response during the infection.
Contrary to SOCS3, IFIT3 is considered to be a positive regulator for
IRF3 activation, and IFIT3 enhances the host antiviral responses (Liu
et al., 2011). The expression of IFIT protein family members is
induced by IFNs, and they inhibit the replication of viruses at
translational level (Diamond and Farzan, 2013). In our infection
experiments we observed that the expression of SOCS3 and IFIT3
mRNA was similar in H3N2 and H9N2-infected cells (Fig. 6A).
Fig. 4. Human H3N2 and avian H9N2 virus-induced inﬂammatory cytokine responses in moDCs. Cells from four different donors are infected with H3N2 or H9N2 viruses
(MOI 1) for different times, cells from different blood donors are pooled and cellular RNA is isolated. The expression of (A) pro-inﬂammatory cytokines CXC10, CCL5, IL-1β and
TNF-α, or (B) IL-12 family subunits p35 and p40 is analyzed by quantitative RT-PCR. The values are normalized to 18S rRNA and presented as relative gene expression in
relation to the uninfected mock sample. Mean values with standard deviations calculated from triplicate measurements are presented. Experiment is a representative of one
out of four. The asterisks indicate statistically signiﬁcant differences between the H3N2 and H9N2 viruses, npo0.05.
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Type I and III IFNs activate the expression of numerous IFN-
inducible genes of antiviral proteins, like PKR, OAS, Mx and IFITM
proteins (Haller and Kochs, 2011; Diamond and Farzan, 2013; Min and
Krug, 2006; Min et al., 2007). The Mx proteins have been shown to
exhibit antiviral activities against inﬂuenza viruses by preventing viral
transcription through an interaction with viral NP (Turan et al., 2004).
ISG15 is another antiviral protein, which is induced by IFNs and has an
ability to inhibit inﬂuenza A and B virus infections (Hsiang et al.,
2009). In addition to MxA and ISG15, IFITM3 is also a signiﬁcant
antiviral protein, which has been shown to restrict infection by several
enveloped viruses including inﬂuenza A virus (Brass et al., 2009). The
expression of antiviral ISG15, IFITM3 and MxA proteins was analyzed
in avian H9N2 and human H3N2 virus-infected moDCs, and we found
out that those proteins were produced almost equally well by H9N2
and H3N2 infections (Fig. 6B). Altogether, these results suggest that the
H9N2 virus is able to induce antiviral status in human cells practically
Fig. 5. Transcription factors IRF3, IRF7 and NFκB are involved in inﬂuenza H3N2 and H9N2 virus-induced cytokine responses. Wild type (wt) mouse embryonic ﬁbroblasts
(MEF) and (A) MEFs devoid of IRF3 and IRF7 transcription factors (IRF3/7 double KO) or (B) MEFs devoid of NF-κB transcription factors (NFκB RelA /c-Rel /Nfκb1 / triple
KO) are infected with H3N2/89 and H9N2/99 viruses (MOI 5) for various periods of times. RNA samples are prepared for analysis of the relative gene expression of M1, IFN-β,
CXCL10 and TNF-α genes. The data is presented as relative gene expression levels for viral M1 gene in relation to that of the 30 min or 1 h sample and for cytokine genes in
relation to those of the mock sample. The results are presented as means from triplicate measurements with standard deviations. Representative experiments out of 2 are
shown. The n symbols indicate signiﬁcant differences between KO and wt cells, npo0.05.
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as efﬁciently as the seasonal H3N2 virus although a temporal
difference in the kinetic of IFN gene expression between these viruses
was seen (Fig. 2A).
The H9N2 avian inﬂuenza virus is extremely sensitive to the antiviral
actions of type I IFNs
After the analysis of the virus-induced antiviral status in infected
cells, we wanted to study whether external cytokines can prevent
the infectivity and replication of the avian-origin H9N2 virus. Thus
we analyzed the antiviral actions of IFN-α, IFN-β, TNF-α and IL-1β
against H3N2 and H9N2 subtype. After pretreating moDCs with
cytokines for 16 h, the cells were infected with these viruses at a
MOI of 1 for another 20 h. RNA samples were collected before and
after infection, and the antiviral activity of different cytokines was
analyzed based on inhibition of viral M1 gene expression. We also
determined MxA gene expression in uninfected cytokine-primed
cells prior to infection. As expected, IFN-α and IFN-β triggered a
signiﬁcant increase in the expression of MxA gene as compared to
an untreated sample (Fig. 7). There was no detectable expression of
MxA gene in TNF-α or IL-1β treated cells (Fig. 7). In IFN-pretreated
and inﬂuenza virus-infected cells the relative copy number of M1
gene decreased in an inverse relation to the IFN dose indicating that
IFN pretreatment efﬁciently inhibited the replication of both types
of inﬂuenza viruses (Fig. 7). This proves that the H9N2 avian
inﬂuenza virus is extremely sensitive to the antiviral actions of
type I IFNs. There was no detectable reduction in the expression of
M1 gene in TNF-α or IL-1β pretreated cells. On the contrary, the
Fig. 6. Comparison of H3N2 and H9N2 virus-induced expression of SOCS3 and antiviral genes in moDCs. Human moDCs from four different blood donors are infected with
H3N2 or H9N2 viruses at MOI of 1 and cellular samples are collected at 0.5, 1, 3, 6, 8 and 24 h time points after infection, cells from different blood donors are pooled and
total cellular RNA and protein samples are prepared. The data is representative of 3 independent experiments. (A) Gene expression of MxA, SOCS3 and IFIT3 mRNA is
determined by quantitative RT-PCR. The values are normalized to 18 S rRNA and presented as relative gene expression in relation to the RNA sample obtained from
uninfected control moDCs. The results are mean values from triplicate measurements with standard deviations. (B) From total cellular proteins the expression levels of ISG15,
IFITM3, MxA and IRF3 are determined by immunoblotting with ECL system. Western blot bands are quantitated and ISG15, IFITM3 and MxA protein expression is presented
in relation to IRF3 as a loading control after which the fold induction over the mock CTRL was calculated.
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replication of both viruses was even increased in TNF-α and IL-1β
pretreated cells. This suggests that inﬂammatory signals (by TNF-α
or IL-1β) may enhance the replication of inﬂuenza viruses, a
phenomenon that deserves further analysis.
Discussion
Avian inﬂuenza A (H9N2) viruses are common in poultry and
wild birds worldwide (Alexander, 2007), which increases the prob-
ability of reassortation with other inﬂuenza viruses circulating in
domestic and wild birds. This has already been seen in the
emergence of H7N9 and H10N8 viruses possessing internal gene
cassettes originating from an avian H9N2 virus (Chen et al., 2014; Liu
et al., 2013). The H9N2 viruses are low pathogenic in avian hosts and
the infection may even be asymptomatic, which enables the virus
and epidemics to remain unrecognized by surveillance systems.
Some H9N2 virus isolates are able to bind to α2,6-linked sialic acid
receptors, the human-type of inﬂuenza receptor (Matrosovich et al.,
2001; Choi et al., 2004), and H9N2 viruses have been occasionally
isolated from humans experiencing an upper respiratory tract
infection. Via reassortation with a human virus, H9N2 virus could
obtain features that might lead to enhanced replication and efﬁcient
transmission in the human host (Wan et al., 2008). Since avian
inﬂuenza viruses are considered to have a signiﬁcant risk of trans-
mission to humans and thus to form a serious public health threat
globally, we analyzed the ability of a human isolate of avian H9N2
virus to replicate and induce innate immune responses in human
immune cells, such as the dendritic cells.
In mouse and chicken experiments it has been shown that LPAI
H9N2 virus activates innate immune responses, including e.g. inter-
feron, pro-inﬂammatory cytokine and interleukin production and
induction of the expression antiviral proteins like Mx1 (Huang et al.,
2013; Lee et al., 2013). Also in human A549 cells it has been shown
that LPAI H9N2 virus infection stimulates type I and III interferon
expression, STAT1 activation and the expression of IFN-stimulated
genes (ISGs) (Sutejo et al., 2012). The present study shows that the
avian-origin inﬂuenza A/Hong Kong/1073/99 (H9N2) virus can
replicate efﬁciently in human DCs and induce both pro-inﬂ-
ammatory and antiviral IFN responses at signiﬁcant level. Although
the H9N2 virus induced early IFN responses in a similar fashion or
even more efﬁciently than the seasonal H3N2 virus did at later time
points of H9N2 infection these responses decreased (Fig. 2A).
Furthermore, the reduced late IFN responses in H9N2 infection
were associated with weaker activation of transcription factors IRF3
and IRF7 at these time points, which is consistent with recent
observations demonstrating impaired IFN responses by the novel
LPAI H7N9 virus in human DCs (Arilahti et al., 2014).
One explanation for the inhibition of late IFN responses in the
H9N2/99 virus-infected cells could be the viral non-structural protein
1 (NS1) which is known to have a major role in inhibiting host innate
immune responses, especially IFN production (Hale et al., 2008). Xing
and coworkers have shown that IFN gene expression was inhibited
by the NS1 of A/pheasant/California/2373/1998 H9N2 virus whereas
the expression of pro-inﬂammatory cytokine genes was not affected
by the functions of NS1 in chicken macrophages (Xing et al., 2009).
Transfer of the NS segment via reassortation from one avian
inﬂuenza virus to another has been shown to have effects on the
pathogenicity of the virus (Ma et al., 2010; Wang et al., 2010). The
early HPAI H5N1 strains (clade 0) as well as the recent LPAI H7N9/
2013 virus have acquired their internal protein encoding genome
segments from the LPAI H9N2 virus lineage which possesses NS1
gene mutations F103LþM106I (Guan et al., 1999). These mutations
have been shown to be associated with increased IFN antagonism,
increased cytoplasmic localization of NS1 protein and altered NS1
interaction with host regulatory proteins (Dankar et al., 2013). Most
of the human virus strains as well as the HPAI H5N1 strains after its
reappearance in 2003 have the same consensus 103F and 106M NS1
protein signature which has been associated with increased CPSF-30
binding activity (Spesock et al., 2011). Further studies are warranted
to reveal the detailed mechanisms of the viral NS1 protein of H9N2
viruses on the antiviral host responses.
Different avian inﬂuenza strains express differences in the tem-
poral activation and the induction levels of the pro-inﬂammatory and
antiviral cytokine responses in human cell systems (Arilahti et al.,
2014; Sutejo et al., 2012; Xing et al., 2011). Although the HPAI H5N1
has been reported to be able to induce strong cytokine responses,
“cytokine storm” in humans (de Jong et al., 2006), in H7N9/2013
avian inﬂuenza virus-infected cells the antiviral IFN responses were
largely impaired (Arilahti et al., 2014). Proinﬂammatory cytokine
responses were also signiﬁcantly weaker in H7N9 virus-infected DCs
as compared to cells infected with the H5N1 or H3N2 viruses
(Arilahti et al., 2014). Our present study characterizing the cytokine
Fig. 7. IFN-mediated antiviral effects against human H3N2 and avian H9N2 viruses.
moDCs are pretreated with 1, 10 or 100 IU/ml of IFN-α and IFN-β or with 1, 10 or
100 ng/ml of IL-1β or with 0.5, 5 or 50 ng/ml of TNF-α for 16 h prior to infection
with H3N2 and H9N2 viruses (MOI 1) for 20 h. Every sample includes cells from
four different blood donors that were pooled. Virus-infected samples are prepared
for viral M1 gene expression analysis by qRT-PCR. Cytokine-primed uninfected
control cells are harvested at the time of inﬂuenza virus infection (16 h after
cytokine pretreatment) for MxA gene expression analysis. The results are mean
values of three replicates with standard deviations from a representative experi-
ment out of two. For IFN-α and IFN-β priming there is a statistically signiﬁcant
decrease and for TNF-α and IL-1-β priming a statistically signiﬁcant increase in the
M1 gene expression (npo0.05) when compared with the unprimed, infected
sample as analyzed with the Student's t test.
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responses in H9N2 virus-infected moDCs is in line with the results by
Xing and colleagues who showed that in human bronchial epithelial
cells infected with the H9N2 virus IFN-β was the prominent antiviral
component together with CXCL10, CCL5 and TNF-α proinﬂammatory
responses, whereas IL-1β, IL-8 and IL-6 might play a minor role in the
pathogenicity (Xing et al., 2011). These virus-speciﬁc differences in
host immune responses to avian inﬂuenza viruses highlight the
importance of studying in more detail the viral determinants con-
tributing to the pathogenicity of inﬂuenza viruses in humans.
Interestingly, we observed that priming the cells with pro-
inﬂammatory cytokines, TNF-α and IL-1β, increased the replication
of the H3N2 and especially the H9N2 inﬂuenza virus (Fig. 7). If such
cytokine-induced inﬂammation is predisposing the cells to support a
more efﬁcient virus replication, this observation could explain the
effective replication of the H5N1 inﬂuenza viruses in humans and
simultaneous robust production of TNF-α and “cytokine storm” (de
Jong et al., 2006). This notion is important also in virus-bacteria co-
infections, since many bacteria capable of causing respiratory infec-
tions induce strong inﬂammatory response with increased cytokine
levels (Latvala et al., 2008; Veckman et al., 2004). Bacteria-induced
pro-inﬂammatory response could thus contribute to further increase
the virus replication at the site of infection.
Although the avian inﬂuenza H9N2 virus is low pathogenic and
causes mainly mild disease in humans, reassortation of H9N2 virus
with other inﬂuenza A virus strains can result in a new type of
reassortant virus with increased virulence and pathogenicity in
humans. This has already occurred in several occasions of which the
most notable one was the emergence of the H7N9 virus in 2013.
Thus, it is important to characterize the innate immune responses
in humans induced also by low pathogenic avian inﬂuenza A viruses
in order to be prepared for any new reassortant viruses and their
speciﬁc properties such as the molecular determinants of patho-
genesis, factors contributing to the ability to replicate in mamma-
lian host and sensitivity to antiviral substances. Our present study
clearly demonstrates that an avian-origin H9N2 virus that was
initially isolated from an infected person in 1999 has the ability to
efﬁciently replicate in human DCs. However, this virus appeared to
have the ability to downregulate IFN gene expression at late times
of infection. Differently from the HPAI H5N1 infection, no “cytokine
storm” was associated with this LPAI H9N2 infection in human DCs,
but rather the immune cells were able to respond to the avian-
origin virus with a similar fashion as to the seasonal human H3N2
virus. We believe that the present study will provide valuable
information for further understanding of innate immunity in
humans during avian inﬂuenza infection.
Materials and methods
Cell cultures
Human primary monocyte-derived DCs (moDCs) were differen-
tiated from peripheral blood monocytes following a standard proce-
dure (Veckman et al., 2004). Buffy coats were obtained from healthy
blood donors (Finnish Red Cross Blood Transfusion Service, Helsinki,
Finland). Peripheral blood mononuclear cells (PBMC) were fractioned
from buffy coats by Ficoll-Paque (Pharmacia Biotech) gradient
centrifugation. Monocytes were puriﬁed from PBMCs by centrifuga-
tion on a Percoll gradient (Amersham Biosciences) following lym-
phocyte depletion with anti-CD3 and anti-CD19 magnetic beads
(Dynal). Monocytes were allowed to adhere to cell culture plates in
RPMI medium (Sigma Aldrich) supplemented with 0.6 mg/ml peni-
cillin, 60 mg/ml streptomycin, 2 mM L-glutamine and 20 mM HEPES.
moDCs were differentiated by culturing monocytes in RPMI medium
(Sigma Aldrich) in the presence of 10% FCS (Integro), 10 ng/ml GM-
CSF (BioSource) and 20 ng/ml IL-4 (Invitrogen Gibcos) for 6 days to
generate cells with the characteristic phenotype of DCs (CD1asemi,
CD40high, CD14) and showing a typical DC morphology (Veckman
et al., 2004; Sallusto and Lanzavecchia, 1994).
Primary wild type (wt) and Irf3 /-Irf7 / mouse embryo
ﬁbroblasts (MEFs) and RelA /c-Rel /Nfκb1 / (NFκB KO) 3T3
cell line were kindly provided by Dr. A. Hoffmann, Signaling
Systems Lab, San Diego. Primary MEFs were immortalized by
rigorous passaging protocol to obtain wt and IRF3/7 KO 3T3 cell
lines. The MEFs and 3T3 cell lines were cultured in DMEM
-medium supplemented with 0.6 mg/ml penicillin, 60 mg/ml strep-
tomycin, 2 mM L-glutamine and 20 mM HEPES and 10% FCS.
Inﬂuenza A viruses
Human inﬂuenza A/Beijing/353/89 (H3N2) virus and human
isolate of an avian inﬂuenza A/Hong Kong/1073/99 (H9N2) virus
(WHO Collaborative Center for Inﬂuenza, London, UK) were grown
in the allantoic cavity of 11-day-old embryonated chicken eggs at
þ36 1C for 3 days.
Hemagglutination assay was done with standard protocol using
0.5% turkey red blood cells. Infective virus titers were determined
by a plaque assay. Viruses were serially diluted and then inocu-
lated to conﬂuent MDCK cells for 1 h at 37 1C. After 1 h the cells
were washed and covered with an agarose overlay (1% agarose and
1 mg/ml TPCK-trypsin in Eagle-MEM). After 3–6 days incubation
the plaques were counted to obtain the concentration of infective
viruses as PFU/ml. The multiplicity of infection (MOI) is given
according to the titers determined in MDCK cells.
Virus infection experiments
Cells were infected with inﬂuenza viruses for different time
periods (15 min to 24 h) as indicated in the ﬁgures. The 3T3 cells
were infected with A/Beijing/353/89 (H3N2) or A/Hong Kong/
1073/99 (H9N2) viruses at multiplicity of infection (MOI) of 5 or
10 as indicated. Human monocyte-derived DCs were infected at
MOI between 0.001 and 100. The propagation of the A/Hong Kong/
1073/99 (H9N2) virus stock and all infection experiments with the
H9N2 virus were carried out under biosafety level 3 (BSL-3)
conditions. The H3N2 and H9N2 viruses were always handled
separately to avoid unintentional reassortation.
IFN priming of virus-infected cells
In IFN priming experiments moDCs were treated with 1, 10 or
100 IU/ml of IFN-α or IFN-β or with 1, 10 or 100 ng/ml of IL-1β or
with 0.5, 5 or 50 ng/ml of TNF-α for 24 h before the cells were
infected with inﬂuenza viruses. Recombinant human IFN-β-1b and
IFN-α-2b were purchased from Schering-Plough and recombinant
human TNF-α and IL-1β2b were from Biosource.
qRT-PCR
Infected cells were harvested and cells from different blood
donors were pooled (Pietilä et al., 2010) before total cellular RNA
was isolated using the RNEasy Mini kit (Qiagen) including DNase
digestion (RNase-free DNase kit, Qiagen). RNA isolation from H9N2/
99 virus-infected cells was carried out in BSL-3 facilities. 0.5 or 1 mg
of total cellular RNAwas transcribed to cDNA using TaqMan Reverse
Transcriptase kit (Applied Biosystems) with random hexamers as
primers. The cDNA was ampliﬁed by PCR using TaqMan Universal
PCR Mastermix and Gene Expression Assays (Applied Biosystems).
The data from human cells was normalized to 18S rRNA with
TaqMan Endogenous Control kit (Applied Biosystems) and for the
mouse cells experiments we used mouse GAPD Endogenous Control
kit (Applied Biosystems). qRT-PCR was done as multiplex (18S or
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GAPD and investigated gene) reactions with triplicate measure-
ments. Gene expression data is presented as fold induction of the
relative gene expression in relation to the unstimulated samples.
For virus replication M1 gene expression data is presented as the
relative gene expression in relation to the 30 min samples which
represent the input amount of the virus. The inﬂuenza A-speciﬁc
primer-probe pair for M1 detects a highly conserved sequence in
the M gene of all inﬂuenza A viruses (Ward et al., 2004). The results
are presented as means from triplicate measurements with stan-
dard deviations. Data from qRT-PCR was analyzed with the Stu-
dent's t test to determine the statistical signiﬁcance of differences
between viruses or knock out/wild type cells. Values of po0.05
were considered signiﬁcant.
ELISA
Levels of secreted IFN-α and IFN-β were analyzed from cell
culture supernatants using VeriKine™ human interferon alpha
Multi-subtype ELISA kit (PBL Assay Science) or VeriKine™ human
IFN beta ELISA kit (PBL Assay Science). The cytokine levels in cell
culture supernatants from different blood donors were analyzed
separately.
Western blot analysis
For Western blot analysis moDCs were harvested and the cells
from four different blood donors were pooled. Cell pellets were lysed
with the passive lysis buffer of the Dual Luciferase Assay Kit
(Promega) containing 1 mM Na3VO4. MEF cells were harvested and
cell pellets lysed with a RIPA buffer (1% Triton X-100, 1% sodium
deoxycholate, 0.1% SDS, 0.15 M NaCl, 0.01 M sodium phosphate, pH
7.2) containing 0.5 mM DTT, 1 mM Na3VO4 and protease inhibitor
mixture (Complete, Roche). Both the moDCs and MEF cell lysates
were boiled for at least 10 min in the Laemmli sample buffer before
taking the samples out of the BSL-3 facilities. Equal volumes of
samples were separated on SDS-PAGE by using the Laemmli buffer
system. After the gel electrophoresis proteins were transferred to
Hybond-P polyvinylidene diﬂuoride (PVDF) membranes (Amersham
Biosciences). The membranes were blocked with 5% milk protein in
PBS or TBS. The primary rabbit antibodies against IRF1, IRF3, IRF7,
MxA, inﬂuenza A NP and M1 were prepared as described previously
(Österlund et al., 2005; Melén et al., 2007; Matikainen et al., 1996;
Ronni et al., 1993). The staining was done in blocking buffer at RT for
1 h. Antibodies for both phosphorylated IRF3 (P-IRF3) and p38 MAPK
(P-p38 MAPK), ISG15, GAPDH and IκBα were commercial antibodies
from Cell Signaling Technology. The antibody against IFITM3 was
from Abgent and the antibody against actin and phosphorylated
STAT1 (P-STAT1) was from Santa Cruz Biotechnology. Staining with
commercial antibodies was done following the manufacturer's
instructions. For the secondary antibody anti-rabbit HRP-conju-
gated antibodies (Dako) were used. Secondary antibody staining
was done at RT for 1 h. Protein bands were visualized on HyperMax
ﬁlms using an ECL plus system (GE Healthcare). When indicated, the
protein band intensities were quantitated with ImageJ software
(http://imagej.nih.gov/ij/) to turn pixel intensity into optical density
(OD). Protein expression data was normalized to the loading controls
and then presented as fold induction of the relative protein expres-
sion in relation to the unstimulated samples.
Flow cytometry
Flow cytometry was used to analyze the viability and maturation
status of moDCs during virus infection. MoDCs were infected with
A/Beijing/353/89 (H3N2) or A/Hong Kong/1073/99 (H9N2) viruses
at multiplicity of infection (MOI) of 1 and cells were harvested after
different time periods (3 h, 8 h and 24 h). The cells from four
different blood donors were collected and handled separately. The
viability of infected cells was determined with LIVE/DEADs Fixable
Far Red Dead Cell Stain Kit (Life Technologies) and staining was
done following the manufacturer's instructions. Cells were ﬁxed
with 90% methanol on ice for 20 min, washed and nonspeciﬁc
binding of antibodies was prevented by keeping the cells in 1% BSA
in PBS. H9N2 virus-infected cells were not released from BSL-3
containment before the methanol ﬁxation. The maturation of
moDCs was analyzed by staining cells with FITC–anti-HLA-II and
PE–anti-CD86 (Caltag Laboratories). The ﬂuorescence-labeled cells
were analyzed with a FACSCanto II ﬂow cytometer using FACSDiva
software (Becton Dickinson).
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